ARS Investment Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2M | Sell |
209,930
-55,234
| -21% | -$9.53M | 2.64% | 12 |
|
|
2025
Q1 | $36.5M | Sell |
265,164
-316
| -0.1% | -$43.5K | 3.3% | 7 |
|
|
2024
Q4 | $36.5M | Buy |
265,480
+2,369
| +0.9% | +$326K | 3.29% | 7 |
|
|
2024
Q3 | $39.3M | Buy |
263,111
+9,972
| +4% | +$1.49M | 3.52% | 7 |
|
|
2024
Q2 | $34.5M | Sell |
253,139
-1,828
| -0.7% | -$249K | 3.3% | 8 |
|
|
2024
Q1 | $38.5M | Sell |
254,967
-27,777
| -10% | -$4.2M | 3.84% | 6 |
|
|
2023
Q4 | $35.6M | Sell |
282,744
-3,174
| -1% | -$400K | 3.95% | 5 |
|
|
2023
Q3 | $26.8M | Sell |
285,918
-3,942
| -1% | -$369K | 3.32% | 6 |
|
|
2023
Q2 | $25.9M | Buy |
289,860
+50,822
| +21% | +$4.54M | 3.02% | 9 |
|
|
2023
Q1 | $25.6M | Buy |
239,038
+417
| +0.2% | +$44.7K | 3.08% | 9 |
|
|
2022
Q4 | $29.1M | Buy |
238,621
+11,194
| +5% | +$1.37M | 3.88% | 4 |
|
|
2022
Q3 | $23.5M | Buy |
227,427
+70,527
| +45% | +$7.28M | 3.23% | 8 |
|
|
2022
Q2 | $14.6M | Buy |
156,900
+18,870
| +14% | +$1.75M | 1.99% | 16 |
|
|
2022
Q1 | $16.2M | Sell |
138,030
-1,643
| -1% | -$193K | 1.56% | 20 |
|
|
2021
Q4 | $18.8M | Buy |
139,673
+18,863
| +16% | +$2.54M | 1.73% | 17 |
|
|
2021
Q3 | $19.3M | Buy |
120,810
+44,558
| +58% | +$7.1M | 1.93% | 15 |
|
|
2021
Q2 | $10M | Buy |
76,252
+1,184
| +2% | +$156K | 1.02% | 32 |
|
|
2021
Q1 | $9.68M | Buy |
75,068
+15,932
| +27% | +$2.05M | 1.12% | 31 |
|
|
2020
Q4 | $9.86M | Buy |
59,136
+15,467
| +35% | +$2.58M | 1.21% | 28 |
|
|
2020
Q3 | $6.74M | Buy |
43,669
+13,098
| +43% | +$2.02M | 1.06% | 30 |
|
|
2020
Q2 | $4.52M | Sell |
30,571
-177
| -0.6% | -$26.2K | 0.85% | 34 |
|
|
2020
Q1 | $3.46M | Buy |
30,748
+15,669
| +104% | +$1.76M | 0.84% | 34 |
|
|
2019
Q4 | $2.1M | Buy |
+15,079
| New | +$2.1M | 0.35% | 53 |
|